AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7353349 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate changes during randomized periods
Number of subjects: 6
Study 12047839 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally relevant nutrition education intervention delivered by bicultural, bilingual Vietnamese‐American nutrition education assistants, consisting of 5 to 7 lessons over an 8-week period.
Number of subjects: 152
Study 12047839 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 152
Study 12047839 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally relevant nutrition education intervention
Number of subjects: 152
Study 30112275 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback targeting the ipsilesional primary motor cortex
Number of subjects: 10
Study 30112275 — intervention group
Group type: COMPARATOR
Intervention: Neurofeedback training of a control brain area
Number of subjects: 10
Study 27982402 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice pack associated with antipyretic
Number of subjects: 102
Study 27982402 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm compress associated with antipyretic
Number of subjects: 102
Study 27982402 — intervention group
Group type: COMPARATOR
Intervention: Antipyretic (Control)
Number of subjects: 102
Study 24399100 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional services (17.8 hours/week for ASD vs 11 hours/week for DD)
Number of subjects: 578
Study 24399100 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicine (CAM)
Number of subjects: 578
Study 24399100 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic medications
Number of subjects: 578
Study 24399100 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental education level
Number of subjects: 578
Study 24399100 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional services (>20 hours/week)
Number of subjects: 578
Study 24399100 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunization status
Number of subjects: 578
Study 22227067 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory constructs (nutrition‐related self‐efficacy, intention, behavioral strategies, family support, situation, outcome expectations, and outcome expectancies)
Number of subjects: 357
Study 22227067 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory constructs
Number of subjects: 357
Study 20718310 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental intervention directed at pregnant women
Number of subjects: 0
Study 18620511 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine treatment (600 mg at day 1, 600 mg at days 2 and 3, 300 mg at days 4 and 5)
Number of subjects: 54
Study 18620511 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 54
Study 16094063 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 ml/kg 0.125% bupivacaine with 1 microg/kg clonidine
Number of subjects: 35
Study 16094063 — intervention group
Group type: COMPARATOR
Intervention: 1 ml/kg 0.125% bupivacaine (controls)
Number of subjects: 35
Study 12165122 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phototherapy and low-intensity laser therapy (LILT) with parameters: 532 mW; 5 kHz; 12 J/cm² for 4 weeks
Number of subjects: 15
Study 12165122 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham treatments)
Number of subjects: 15
Study 9933035 — intervention group
Group type: EXPERIMENTAL
Intervention: TUMT plus tamsulosin (0.4 mg daily)
Number of subjects: 81
Study 9933035 — intervention group
Group type: COMPARATOR
Intervention: TUMT alone
Number of subjects: 81
Study 7772590 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthoptic exercises/treatment
Number of subjects: 52
Study 7772590 — intervention group
Group type: COMPARATOR
Intervention: Monitoring for signs of spontaneous recovery
Number of subjects: 52
Study 2177647 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens 1.25 mg daily + dydrogesterone 20 mg daily for 12 days during months 2, 3, and 4, then 10 mg daily for the same duration in months 5, 6, and 7
Number of subjects: 14
Study 2177647 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens 1.25 mg daily + dydrogesterone (two doses in reverse sequence)
Number of subjects: 14
Study 2177647 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine oestrogens 1.25 mg daily
Number of subjects: 14
Study 2177647 — intervention group
Group type: COMPARATOR
Intervention: Untreated reference group of eight postmenopausal women
Number of subjects: 14
Study 6255535 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg daily)
Number of subjects: 50
Study 6255535 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin (250 mg daily)
Number of subjects: 50
Study 30396226 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine aspirin 75 mg
Number of subjects: 546
Study 30396226 — intervention group
Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 546
Study 28528242 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg/day
Number of subjects: 40
Study 28528242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 26043035 — intervention group
Group type: COMPARATOR
Intervention: Dietary intervention (part of CAFAP)
Number of subjects: 69
Study 23483886 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening chronotype
Number of subjects: 119
Study 21629014 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 46
Study 21629014 — intervention group
Group type: COMPARATOR
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 46
Study 20175428 — intervention group
Group type: EXPERIMENTAL
Intervention: Running trial (60 min, including 15-min warm-up at 75-80% HR(peak) + 45 min at 85-90% HR(peak))
Number of subjects: 8
Study 20175428 — intervention group
Group type: EXPERIMENTAL
Intervention: Running trial (60 min)
Number of subjects: 8
Study 16570816 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Budesonide (256 microg once daily intranasally for 8 weeks)
Number of subjects: 42
Study 12808485 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of atorvastatin every day
Number of subjects: 54
Study 12808485 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of atorvastatin every other day
Number of subjects: 54
Study 12808485 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of atorvastatin every other day
Number of subjects: 54
Study 11892324 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8632574 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteinizing hormone‐releasing hormone agonist therapy for 12 weeks
Number of subjects: 56
Study 8632574 — intervention group
Group type: COMPARATOR
Intervention: Immediate radical retropubic prostatectomy
Number of subjects: 56
Study 8632574 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis by pretreatment PSA levels
Number of subjects: 56
Study 1999793 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA morphine
Number of subjects: 82
Study 1999793 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA morphine with low-dose continuous morphine infusion (PCA-plus)
Number of subjects: 82
Study 1999793 — intervention group
Group type: COMPARATOR
Intervention: Intramuscularly administered morphine
Number of subjects: 82
Study 6628007 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygroscopic condensor humidifier (HCH)
Number of subjects: 26
Study 6628007 — intervention group
Group type: COMPARATOR
Intervention: Conventional cascade humidification
Number of subjects: 26
Study 30770850 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-resolution local binary patterns (MLBP)
Number of subjects: 0
Study 27332677 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 136
Study 27332677 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid stenting (CAS)
Number of subjects: 136
Study 25394822 — intervention group
Group type: EXPERIMENTAL
Intervention: Kin Keeper(SM) Cancer Prevention Intervention, delivered by community health workers, including two cancer education home visits, costing $151/family.
Number of subjects: 0
Study 25394822 — intervention group
Group type: EXPERIMENTAL
Intervention: Kin Keeper(SM) Cancer Prevention Intervention
Number of subjects: 0
Study 23630215 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT)
Number of subjects: 1543
Study 23630215 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 1543
Study 21642642 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 ml kg(‐1) ropivacaine
Number of subjects: 75
Study 21642642 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 ml kg(‐1) ropivacaine
Number of subjects: 75
Study 21642642 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3 ml kg(‐1) ropivacaine
Number of subjects: 75
Study 19539813 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness perception intervention (one half‐hour session with a psychologist)
Number of subjects: 57
Study 19539813 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 57
Study 16934729 — intervention group
Group type: EXPERIMENTAL
Intervention: Backache Index (BAI)
Number of subjects: 75
Study 16934729 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep transverse friction myotherapy (after two treatment sessions)
Number of subjects: 75
Study 15566342 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of evidence-based fetal health surveillance guideline
Number of subjects: 51
Study 15566342 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline recommendations
Number of subjects: 51
Study 15566342 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practice implementation
Number of subjects: 51
Study 11737959 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A plus Fe supplementation (4800 retinol equivalent vitamin A, 120 mg Fe, and 500 microg folic acid)
Number of subjects: 0
Study 11737959 — intervention group
Group type: COMPARATOR
Intervention: Fe supplementation alone (120 mg Fe and 500 microg folic acid)
Number of subjects: 0
Study 11737959 — intervention group
Group type: COMPARATOR
Intervention: Fe status, weight and length of infants
Number of subjects: 0
Study 11737959 — intervention group
Group type: COMPARATOR
Intervention: Fe status of girls
Number of subjects: 0
Study 11737959 — intervention group
Group type: COMPARATOR
Intervention: Boys
Number of subjects: 0
Study 9881325 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg 17 beta‐oestradiol daily on days 1‐28, combined with either 5 or 10 mg dydrogesterone on days 15‐28 for 12 months (13 cycles of 28 days)
Number of subjects: 154
Study 7867285 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with plasma exchange and immune globulins
Number of subjects: 0
Study 7867285 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 2522007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (60 mg daily, for two months)
Number of subjects: 17
Study 2522007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 17
Study 31211691 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia
Number of subjects: 9
Study 31211691 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 9
Study 29262795 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 900 mg once daily for six months
Number of subjects: 980
Study 29262795 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar-looking placebo tablets)
Number of subjects: 980
Study 29262795 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 980
Study 29262795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 980
Study 25530306 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger Self-Management Training (ASMT)
Number of subjects: 0
Study 25530306 — intervention group
Group type: COMPARATOR
Intervention: Personal Readjustment and Education (PRE)
Number of subjects: 0
Study 23767916 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU of vitamin D3 per day (low dose)
Number of subjects: 45
Study 23767916 — intervention group
Group type: EXPERIMENTAL
Intervention: 4,370 IU of vitamin D3 per day (high dose)
Number of subjects: 45
Study 23767916 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 45
Study 21956102 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg micronized estradiol (E2)
Number of subjects: 33
Study 21956102 — intervention group
Group type: EXPERIMENTAL
Intervention: 2mg micronized estradiol and 1mg norethisterone acetate (E2+NETA)
Number of subjects: 33
Study 21956102 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5mg tibolone (T)
Number of subjects: 33
Study 21956102 — intervention group
Group type: COMPARATOR
Intervention: No hormone replacement therapy (no HRT)
Number of subjects: 33
Study 18471588 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held computer (PDA) intervention with daily feedback and goal-setting
Number of subjects: 27
Study 18471588 — intervention group
Group type: COMPARATOR
Intervention: Standard written nutritional education materials (Control)
Number of subjects: 27
Study 17072706 — intervention group
Group type: EXPERIMENTAL
Intervention: Parker Flex‐Tip tube (PFT)
Number of subjects: 134
Study 17072706 — intervention group
Group type: COMPARATOR
Intervention: Standard endotracheal tube (SET)
Number of subjects: 134
Study 12453903 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg b.i.d.)
Number of subjects: 45
Study 12453903 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1 g b.i.d.)
Number of subjects: 45
Study 12453903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 10084185 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable electrical stimulation
Number of subjects: 130
Study 10084185 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulated group
Number of subjects: 130
Study 10084185 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable electrical stimulation (workers' compensation subset)
Number of subjects: 130
Study 10084185 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulated group (workers' compensation subset)
Number of subjects: 130
Study 7672138 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (long‐acting somatostatin analogue) administered SC for 6 weeks
Number of subjects: 20
Study 1973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0
Study 1973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 0
Study 1973546 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 1973546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7412158 — intervention group
Group type: EXPERIMENTAL
Intervention: Methazolamide (oral doses)
Number of subjects: 11
Study 7412158 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide (oral medication)
Number of subjects: 11
Study 6094444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime peroperatively for 24 h
Number of subjects: 201
Study 6094444 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/tinidazole peroperatively for 24 h
Number of subjects: 201
Study 6094444 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotic
Number of subjects: 201
Study 30689707 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg bid)
Number of subjects: 302
Study 30689707 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy treatment of physician's choice (TPC)
Number of subjects: 302
Study 30689707 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 302
Study 30338823 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (3-4 courses of cisplatin, ifosfamide, and adriamycin)
Number of subjects: 278
Study 30338823 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy (control group)
Number of subjects: 278
Study 26582310 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 61
Study 26582310 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 24280811 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron-dexamethasone combination (0.075 mg palonosetron and 8 mg dexamethasone)
Number of subjects: 84
Study 24280811 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron (0.075 mg)
Number of subjects: 84
Study 22710099 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplementation with olive leaves (10 g/kg)
Number of subjects: 0
Study 22710099 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplementation with α‐tocopheryl acetate (200 mg/kg)
Number of subjects: 0
Study 22710099 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet supplementation with linseed oil
Number of subjects: 0
Study 20368558 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus IFN‐alpha
Number of subjects: 732
Study 20368558 — intervention group
Group type: COMPARATOR
Intervention: IFN‐alpha monotherapy
Number of subjects: 732
Study 17585667 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture regulating the Governor vessel (Fengfu (GV 16), Dazhui (GV 14), Baihui (GV 20), etc.)
Number of subjects: 98
Study 17585667 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture at Jiaji points (C3 - C7 Jiaji points (EX-B 2) and Fengchi (GB 20))
Number of subjects: 98
Study 15619462 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupported drawing
Number of subjects: 0
Study 15619462 — intervention group
Group type: COMPARATOR
Intervention: Supported drawing
Number of subjects: 0
Study 15619462 — intervention group
Group type: EXPERIMENTAL
Intervention: Freehand spirals
Number of subjects: 0
Study 15619462 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant hand drawing
Number of subjects: 0
Study 15619462 — intervention group
Group type: EXPERIMENTAL
Intervention: Effort levels (normal, slow, soft, rapid)
Number of subjects: 0
Study 15619462 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater and intra-rater reliability for unsupported drawings
Number of subjects: 0
Study 15619462 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-rater and intra-rater reliability for freehand drawings
Number of subjects: 0
Study 11934082 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week smoking cessation program plus a 3-times-per-week exercise program
Number of subjects: 281
Study 11934082 — intervention group
Group type: COMPARATOR
Intervention: Contact control wellness program
Number of subjects: 281
Study 10075324 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% fat diet (2.7% saturates) for 10 days
Number of subjects: 38
Study 10075324 — intervention group
Group type: COMPARATOR
Intervention: 20-24% fat diets
Number of subjects: 38
Study 8635032 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive multimedia program
Number of subjects: 60
Study 8635032 — intervention group
Group type: COMPARATOR
Intervention: Brochure
Number of subjects: 60
Study 8635032 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered behavior by physicians
Number of subjects: 60
Study 2206836 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac gel (Voltarol Emulgel) 4 g tds
Number of subjects: 384
Study 2206836 — intervention group
Group type: COMPARATOR
Intervention: felbinac gel (Traxam) 4 g tds
Number of subjects: 384
Study 6108335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam (once-daily)
Number of subjects: 222
Study 6108335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam (three-times-daily)
Number of subjects: 222
Study 6108335 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 222
Study 6108335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 31159837 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid fixation (using ESIN for the radius and ORIF for the ulna)
Number of subjects: 0
Study 31159837 — intervention group
Group type: COMPARATOR
Intervention: Double plate fixation
Number of subjects: 0
Study 31159837 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid fixation
Number of subjects: 0
Study 29535271 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility-weighted modified Rankin Scale (UW-mRS)
Number of subjects: 500
Study 29535271 — intervention group
Group type: COMPARATOR
Intervention: Dichotomous mRS approach
Number of subjects: 500
Study 29535271 — intervention group
Group type: COMPARATOR
Intervention: Ordinal mRS approach
Number of subjects: 500
Study 26715227 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 12
Study 25018069 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized scan delay of 20 seconds
Number of subjects: 150
Study 25018069 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized scan delay of 30 seconds
Number of subjects: 150
Study 23049924 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate treatment
Number of subjects: 494
Study 23049924 — intervention group
Group type: COMPARATOR
Intervention: Folinate rescue therapy
Number of subjects: 494
Study 19734013 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-switching performance under high context demands
Number of subjects: 0
Study 19734013 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-switching performance under low context demands
Number of subjects: 0
Study 19734013 — intervention group
Group type: EXPERIMENTAL
Intervention: Context processing deficits in schizophrenia
Number of subjects: 0
Study 19734013 — intervention group
Group type: EXPERIMENTAL
Intervention: Influence of PFC impairments on task-switching performance
Number of subjects: 0
Study 16988651 — intervention group
Group type: EXPERIMENTAL
Intervention: Arabinoxylan (AX) supplement 15 g
Number of subjects: 11
Study 16988651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 16269401 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA 150 mg daily and Low Molecular Weight Heparin (LMWH) 5000 IU x2 for three days
Number of subjects: 14
Study 16269401 — intervention group
Group type: COMPARATOR
Intervention: Acetyl salicylic acid (ASA) 150 mg daily
Number of subjects: 14
Study 16269401 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14